InvestorsHub Logo
Followers 134
Posts 3756
Boards Moderated 0
Alias Born 01/28/2006

Re: scottsmith post# 321040

Thursday, 08/27/2020 12:29:27 PM

Thursday, August 27, 2020 12:29:27 PM

Post# of 403586
Dr DeGrado has been extremely successful. He heads the Degrado Institute at the University of San Francisco. The Degrado Institute is involved with scores of research projects which primarily deal with protein science. Dr DeGrado is an international expert in his field.

It is almost unheard of for a scientist of his standing to take on a position with a small company like IPIX. Usually individuals in his position will recommend an associate or a younger researcher. The fact he has accepted the position at IPIX is a complement to Leo Ehrlich and IPIX as well as a validation of Brilacidin's science.

Having a world renown scientist to guide Brilacidin through the clinical trials will help Brilacidin in every way. Dr DeGrado's connections are international in scope with universities,government and industry. A tenured scientist such as Dr DeGrdo is not looking for opportunities to fail. He has taken on the position as Brilacidin's science advisor for one reason; he wants to be part of the team that develops Brilacidin as a Covid 19 treatment.

GLTA,Farrell

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News